C

Cyclacel Pharmaceuticals
D

CYCC

0.23520
USD
-0.02
(-7.76%)
مغلق
حجم التداول
2,252
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
5,588,229
أصول ذات صلة
A
ARAY
0.01000
(0.71%)
1.41000 USD
A
AXSM
1.415
(1.36%)
105.335 USD
B
BCLI
0.00000
(0.00%)
1.16000 USD
C
CRBP
-0.15750
(-2.03%)
7.60000 USD
C
CYCCP
-0.22000
(-3.73%)
5.68000 USD
J
JAGX
0.03000
(1.18%)
2.58000 USD
K
KZIA
0.56000
(8.50%)
7.15000 USD
P
PAVM
-0.00080
(-0.13%)
0.59870 USD
V
VKTX
0.430
(1.55%)
28.150 USD
المزيد
الأخبار المقالات

العنوان: Cyclacel Pharmaceuticals Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.